SC
ALKS icon

Stempoint Capital’s Alkermes ALKS Stock Holding History

Stempoint Capital’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.85M Buy
+80,492
New +$2.5M 0.54% 48
2025
Q4 		– Sell
-241,637
Closed -$7.25M – 81
2025
Q3 		$7.25M Sell
241,637
-109,487
-31% -$3.09M 1.45% 22
2025
Q2 		$10M Buy
351,124
+158,772
+83% +$4.73M 3.22% 10
2025
Q1 		$6.35M Sell
192,352
-224,616
-54% -$7.33M 2.02% 20
2024
Q4 		$12M Buy
416,968
+368,050
+752% +$10.6M 2.99% 8
2024
Q3 		$1.37M Buy
+48,918
New +$1.3M 0.41% 44

Other funds holding ALKS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Stempoint Capital's ALKS Position: Q1 2026 in Review

Stempoint Capital opened a new position in Alkermes (ALKS) in Q1 2026: 80,492 shares worth $2.85M. The stake represents 0.54% of the portfolio and ranks #48 among its holdings. This is a return to the name: Stempoint Capital previously reported a position in ALKS as recently as Q3 2025.

Stempoint Capital first reported a position in ALKS in Q3 2024 and has held it in 6 quarters since. The position peaked at $12M in Q4 2024. 388 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • Stempoint Capital held 80,492 shares of Alkermes worth $2.85M as of Q1 2026.
  • Alkermes was a new Stempoint Capital position in Q1 2026.
  • Alkermes made up 0.54% of Stempoint Capital's portfolio in Q1 2026, its #48 holding.
  • Stempoint Capital first reported a position in Alkermes in Q3 2024 and has held it in 6 quarters since.
  • Stempoint Capital's Alkermes position peaked at $12M in Q4 2024.
  • 388 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Stempoint Capital's 13F filing for Q1 2026, filed 15 May 2026.